Multiple Sclerosis

Multiple sclerosis (MS) is a severe autoimmune disease of the central nervous system that affects the brain and spinal cord, causing problems with muscle movement, balance and vision.

Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a neurodegenerative disorder that damages the nerves in the brain and spinal cord, leading to problems with muscle movement, balance and vision.

What Causes Multiple Sclerosis?

Relapsing-Remitting Multiple Sclerosis (RRMS)

Multiple sclerosis and smoking

Multiple sclerosis and beta interferon

Multiple Sclerosis and Women’s Health

Primary Progressive Multiple Sclerosis (PPMS)

Remyelination Strategies for Multiple Sclerosis

Cognitive Impairment and Multiple Sclerosis

Multiple Sclerosis Epidemiology

Multiple Sclerosis and Pregnancy

See more featured articles »

Early Signs of Multiple Sclerosis

At-Home Physiotherapy Exercises for Multiple Sclerosis

Working Towards Earlier Diagnosis of Multiple Sclerosis

How is RRMS Different from PPMS and SPMS?

Anti-Myelin Antibodies in Multiple Sclerosis

Secondary Progressive Multiple Sclerosis (SPMS)

Types of Multiple Sclerosis (MS)

Epigenetics for Multiple Sclerosis

Heat Intolerance in Multiple Sclerosis

Multiple Sclerosis in Children

Optic Neuritis and Multiple Sclerosis

Benign Multiple Sclerosis (MS)

Latest Multiple Sclerosis News and Research

Brain organoid studies on the ISS move closer to new treatments

Research using human brain organoids onboard the International Space Station International Space Station (ISS) helped lead to the clinical trial of a potential therapy for Rett syndrome, a debilitating neurological disorder in children.

20 Aug 2026

Paternal valproate use not linked to offspring neurodevelopmental risks

Use of the antiseizure drug valproate by fathers before conception is not associated with neurodevelopmental disorders like autism or attention-deficit/hyperactivity disorder (ADHD) in their children, according to a new study published August 19, 2026, in Neurology®, an official journal of the American Academy of Neurology.

19 Aug 2026

Later-life estrogen therapy associated with lower risk of developing dementia

Use of hormone therapy later in life was associated with lower risk of developing dementia, according to a study published August 12, 2026, in Neurology, the medical journal of the American Academy of Neurology.

12 Aug 2026

FDA clears first self-balancing personal exoskeleton for wheelchair users

The U.S. Food and Drug Administration has cleared Eve™, the first self-balancing personal exoskeleton for eligible wheelchair users living with spinal cord injury.

11 Aug 2026

New report shows rising job search among disabled individuals

More people with disabilities were actively looking for work in July compared to June, while the number of people without disabilities seeking employment declined over the same period.

10 Aug 2026

Study reveals treatment gaps for atypical Alzheimer's disease patients

Many people with less common forms of Alzheimer's disease may not qualify for newer anti-amyloid treatments designed to slow the disease, according to a study published August 5, 2026, in Neurology®, the medical journal of the American Academy of Neurology.

5 Aug 2026

Australian-first twin study aims to to unlock new insights into immune health

An Australian-first study of twins will seek to find out why two genetically similar people respond differently to infections, diseases and treatments.

4 Aug 2026

New blood marker could help track MS progression and monitor treatment response

Modern therapies have transformed care for people with multiple sclerosis (MS). Yet the disease continues to progress in a substantial proportion of patients, even in the absence of relapses.

3 Aug 2026

ALS risk varies significantly across U.S. military service branches

Compared to Army veterans, men who are veterans of the U.S. Air Force, Navy and Coast Guard have higher rates of amyotrophic lateral sclerosis (ALS), and men who are Marine veterans have lower rates, according to a new study published July 29, 2026, in Neurology®, an official journal of the American Academy of Neurology.

29 Jul 2026

Early-life sugar restriction may reduce dementia risk later

Consuming less sugar in utero before birth and during the first one to two years of life was associated with a lower risk of developing dementia later in life, according to a study published July 29, 2026, in Neurology, the medical journal of the American Academy of Neurology.

29 Jul 2026

Multiple sclerosis mortality trends underscore need for comprehensive patient care

An analysis of more than 42,000 U.S. deaths linked to multiple sclerosis (MS) found that death rates varied by age, geography, and race and ethnicity, with Black patients dying younger than white patients and high blood pressure emerging as a growing contributor.

22 Jul 2026

Plasma exchange improves recovery in rare inflammatory nerve disease

Plasma exchange can help treat people with a rare inflammatory disease that can cause blindness, according to a systematic review and meta-analysis published on July 22, 2026, in Neurology, the medical journal of the American Academy of Neurology.

22 Jul 2026

Multiple sclerosis deaths occur earlier among Black patients

Black people with multiple sclerosis (MS) die from MS at a younger age than white people, with a peak mortality rate at ages 65 to 74 for Black people and ages 75 to 84 for white people, according to a study published July 22, 2026, in Neurology® Open Access, an official journal of the American Academy of Neurology.

22 Jul 2026

Gut immune cells may improve multiple sclerosis treatment outcomes

B-cell depletion therapies, in which B cells of the immune system, which may drive disease activity in multiple sclerosis (MS), are temporarily removed, have contributed significantly to improved treatment for patients in recent years.

22 Jul 2026

Mount Sinai establishes new autoimmunity center with $5 million gift

A $5 million gift from philanthropists Judith and Stewart Colton will establish a Colton Center for Autoimmunity within the Marc and Jennifer Lipschultz Precision Immunology Institute (PrIISM) at the Icahn School of Medicine at Mount Sinai.

21 Jul 2026

$Novel salvage surgical approach for refractory multiple sclerosis-related trigeminal neuralgia$